Biochemical Changes of Extracellular Proteoglycans in Squamous Cell Laryngeal Carcinoma

REFERENCES

• Sessions R.B., Harrison L.B., Forastiere A.A. Tumors of the larynx and hypopharynx. Cancer: Principles and Practice of Oncology 6th ed., V.T. DeVita, S. Hellman, S.A. Rosenberg. Lippincott Williams & Wilkins, Philadelphia 2001; 861–886
   Google Scholar
• Schwartz G.J., Wenig B.L. Clinical considerations for neoplasms of the larynx. Head and Neck Pathology with Clinical Correlations, , et al. Churchill Livingstone, Philadelphia 1998; 330–360
   Google Scholar
• Skandalis S.S., Stylianou M., Vynios D. H., Papageorgakopoulou N., Theocharis D.A. The structural and compositional changes of glycosaminoglycans are closely associated with tissue type in human laryngeal cancer. Biochimie 2007, doi:10.1016/j.biochi.2007.07.006
   PubMed Web of Science ®Google Scholar
• Skandalis S.S., Theocharis A.D., Papageorgakopoulou N., Vynios D.H., Theocharis D.A. The increased accumulation of structurally modified versican and decorin is related with the progression of laryngeal cancer. Biochimie 2006; 88: 1135–1143
   PubMed Web of Science ®Google Scholar
• Skandalis S.S., Theocharis A.D., Vynios D.H., Papageorgakopoulou N., Hjerpe A., Karamanos N.K., Theocharis D.A. Cartilage aggregable aggrecan undergoes significant compositional and structural alterations during laryngeal cancer. Biochim. Biophys. Acta 2006; 1760: 1046–1053
   PubMed Web of Science ®Google Scholar
• Stylianou M., Skandalis S.S., Papadas T.A., Mastronikolis N.S., Theocharis D.A., Papageorgakopoulou N., Vynios D.H. Stage-related decorin and versican expression in human laryngeal cancer. Anticancer Res. 2008; 28: 245–251
   PubMed Web of Science ®Google Scholar
• Christopoulos T.A., Papageorgakopoulou N., Theocharis D.A., Aletras A.J., Tsiganos C.P., Papadas T.A., Mastronikolis N.S., Goumas P., Vynios D.H. Diagnostic and classification value of metalloproteinases in squamous human laryngeal carcinoma. Int. J. Oncol. 2004; 25: 481–485
   PubMed Web of Science ®Google Scholar
• Christopoulos T.A., Papageorgakopoulou N., Ravazoula P., Mastronikolis N.S., Papadas T.A., Theocharis D.A., Vynios D.H. Expression of metalloproteinases and their tissue inhibitors in squamous cell laryngeal carcinoma. Oncol. Rep. 2007; 18: 855–860
   PubMed Web of Science ®Google Scholar
• Papadas Th.A., Stylianou M., Mastronikolis N.S., Papageorgakopoulou N., Skandalis S.S., Goumas P., Theocharis D.A., Vynios D.H. Alterations in the content and composition of glycosaminoglycans in human laryngeal carcinoma. Acta Otolaryngol. 2002; 122: 330–337
   PubMed Web of Science ®Google Scholar
• Tsara M.E., Theocharis A.D., Theocharis D.A. Compositional and structural alterations of proteoglycans in human rectum carcinoma with special reference to versican and decorin. Anticancer Res. 2002; 22: 2893–2898
   PubMed Web of Science ®Google Scholar
• Jayson G.C., Lyon M., Paraskeva C., Turnbull J.E., Deakin J.A., Gallagher J.T. Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J. Biol. Chem. 1998; 273: 51–57
   PubMed Web of Science ®Google Scholar
• Theocharis A.D. Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochim. Biophys. Acta 2002; 1588: 165–172
   PubMed Web of Science ®Google Scholar
• Theocharis A.D., Vynios D.H., Papageorgakopoulou N., Skandalis S.S., Theocharis D.A. Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma. Int. J. Biochem. Cell Biol. 2003; 35: 376–390
   PubMed Web of Science ®Google Scholar
• Kovalszky I., Pogany G., Molnar G., Jeney A., Lapis K., Karacsonyi S., Szecseny A., Iozzo R.V. Altered glycosaminoglycan composition in reactive and neoplastic human liver. Biochem. Biophys. Res. Commun. 1990; 167: 883–890
   PubMed Web of Science ®Google Scholar
• Theocharis A.D., Tsara M.E., Papageorgacopoulou N., Karavias D.D., Theocharis D.A. Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition. Biochim. Biophys. Acta 2000; 1502: 201–206
   PubMed Web of Science ®Google Scholar
• Skandalis S.S., Kletsas D., Kyriakopoulou D., Stavropoulos M., Theocharis D.A. The greatly increased amounts of accumulated versican and decorin with specific post-translational modifications may be closely associated with the malignant phenotype of pancreatic cancer. Biochim. Biophys. Acta 2006; 1760: 1217–1225
   PubMed Web of Science ®Google Scholar
• Theocharis A.D., Theocharis D.A. High-performance capillary electrophoretic analysis of hyaluronan and galactosaminoglycan-disaccharides in gastrointenstinal carcinomas. Differential disaccharide composition as a possible tool-indicator for malignancies. Biomed. Chromatogr. 2002; 16: 157–161
   PubMed Web of Science ®Google Scholar
• Merle B., Durussel L., Delmas P.D., Clecardin P. Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain. J. Cell. Biochem. 1999; 75: 538–546
   PubMed Web of Science ®Google Scholar
• Stern R., Asari A.A., Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur. J. Cell Biol. 2006; 85: 699–715
   PubMed Web of Science ®Google Scholar
• Takahashi Y., Li L., Kamiryo M., Asteriou T., Moustakas A., Yamashita H., Heldin P. Hyaluronan fragments induce endothelial cell differentiation in a CD44- and CXCL1/GRO1-dependent manner. J. Biol. Chem. 2005; 280: 24195–24204
   PubMed Web of Science ®Google Scholar
• Christopoulos T.A., Papageorgakopoulou N., Theocharis D.A., Mastronikolis N.S., Papadas T.A., Vynios D.H. Hyaluronidase and CD44 hyaluronan receptor expression in squamous cell laryngeal carcinoma. Biochim. Biophys. Acta 2006; 1760: 1039–1045
   PubMed Web of Science ®Google Scholar
• Brinck J., Heldin P. Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44. Exp. Cell Res. 1999; 252: 342–351
   PubMed Web of Science ®Google Scholar
• Adamia S., Maxwell C.A., Pilarski L.M. Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2005; 5: 3–14
   PubMedGoogle Scholar